Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/18938
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVANDERSTEEGEN, Tom-
dc.contributor.authorMARNEFFE, Wim-
dc.contributor.authorVANDIJCK, Dominique-
dc.date.accessioned2015-06-12T07:27:24Z-
dc.date.available2015-06-12T07:27:24Z-
dc.date.issued2015-
dc.identifier.citationACTA CLINICA BELGICA 70 (6), p. 396-397-
dc.identifier.issn1784-3286-
dc.identifier.urihttp://hdl.handle.net/1942/18938-
dc.language.isoen-
dc.rights© 2015 Acta Clinica Belgica-
dc.subject.otherdefensive medicine; non-disclosure; quality of care; healthcare costs; adverse event-
dc.titleDefensive medicine: implications for clinical practice, patients and healthcare policy-
dc.typeJournal Contribution-
dc.identifier.epage397-
dc.identifier.issue6-
dc.identifier.spage396-
dc.identifier.volume70-
local.bibliographicCitation.jcatA1-
dc.description.notesVandersteegen, T (reprint author), Martelarenlaan 42, B-3500 Hasselt, Belgium. tom.vandersteegen@uhasselt.be-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1179/2295333715Y.0000000037-
dc.identifier.isi000369185300002-
item.fulltextWith Fulltext-
item.contributorVANDERSTEEGEN, Tom-
item.contributorMARNEFFE, Wim-
item.contributorVANDIJCK, Dominique-
item.fullcitationVANDERSTEEGEN, Tom; MARNEFFE, Wim & VANDIJCK, Dominique (2015) Defensive medicine: implications for clinical practice, patients and healthcare policy. In: ACTA CLINICA BELGICA 70 (6), p. 396-397.-
item.accessRightsRestricted Access-
item.validationecoom 2017-
crisitem.journal.issn1784-3286-
crisitem.journal.eissn2295-3337-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Published article.pdf
  Restricted Access		Published version346.95 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.